Corbus Pharmaceuticals Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $19.66 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2026-03-09
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $19.66M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $13.69M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $11.56M; Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed $11.56M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $7.27M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2025-12-31 | $19.66M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $13.69M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $11.56M 10-K · filed 2025-03-11 | $11.56M 10-K · filed 2024-03-12 |
| 2022-12-31 | $7.27M 10-K · filed 2024-03-12 | |
| 2021-12-31 | $5.85M 10-K · filed 2023-03-07 | |
| 2020-12-31 | $10.53M 10-K · filed 2022-03-08 | |
| 2019-12-31 | $10.88M 10-K · filed 2021-03-15 | |
| 2018-12-31 | $3.62M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |